Equities

Shanghai MicroPort Endovascular MedTech Group Co Ltd

688016:SHH

Shanghai MicroPort Endovascular MedTech Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)181.50
  • Today's Change-1.02 / -0.56%
  • Shares traded642.81k
  • 1 Year change+9.67%
  • Beta0.8826
Data delayed at least 15 minutes, as of Mar 13 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai MicroPort Endovascular MedTech Group Co Ltd, formerly Shanghai MicroPort Endovascular MedTech Co Ltd, is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.

  • Revenue in CNY (TTM)1.26bn
  • Net income in CNY551.89m
  • Incorporated2012
  • Employees908.00
  • Location
    Shanghai MicroPort Endovascular MedTech Group Co LtdNo. 1, Lane 3399, Kangxin HighwayPudong New AreaSHANGHAI 201318ChinaCHN
  • Phone+86 2 138139300
  • Fax+86 2 133750026
  • Websitehttps://www.endovastec.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shinva Medical Instrument Co Ltd10.10bn668.52m11.01bn8.21k16.421.46--1.091.441.4421.6216.180.67852.225.361,230,542.004.634.639.1810.7626.2224.226.836.120.7893--0.17615.917.87-0.534230.7895.70-5.9061.86
Shanghai Microport EP MedTech Co Ltd366.21m19.18m12.12bn577.00631.597.17--33.090.04080.04080.77823.590.20131.189.01634,687.401.05--1.11--61.35--5.24--12.39--0.014--26.46--85.17------
Micro-Tech Nanjing Co Ltd2.48bn527.90m13.87bn2.40k26.253.72--5.592.812.8113.2319.860.59481.626.911,032,216.0012.9110.7414.9812.8264.8163.0421.7119.375.19--0.0135.4321.7821.2046.9920.3239.33--
Shenzhen YHLO Biotech Co Ltd1.82bn339.81m14.40bn1.76k42.555.48--7.890.59560.59563.214.620.47981.114.911,037,196.007.0316.439.1224.1662.1453.2614.6620.011.50--0.187230.28-48.4223.02-64.9356.3228.88--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.26bn551.89m15.62bn908.0025.833.86--12.407.317.3116.8048.870.37691.607.961,387,329.0016.3517.6818.1219.4375.6176.6043.3942.259.49--0.00844.4632.4338.7237.9840.2850.18--
Beijing Balance Medical Technolgy Co Ltd382.01m111.83m15.73bn473.00141.9213.03--41.180.81150.81152.778.840.30611.065.72807,636.208.168.068.488.4089.4089.4126.6730.029.77--0.009469.1925.5727.3521.0928.10125.94--
Eyebright Medical Tchnlgy Beijing Co Ltd1.07bn328.48m16.63bn2.07k50.727.51--15.523.123.1210.1621.050.40031.995.19516,774.6011.519.9913.2711.1672.2481.2928.7434.662.48--0.133919.9164.1449.5930.6371.8038.83--
Data as of Mar 13 2024. Currency figures normalised to Shanghai MicroPort Endovascular MedTech Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

10.14%Per cent of shares held by top holders
HolderShares% Held
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 20232.08m2.89%
Harvest Fund Management Co., Ltd.as of 30 Sep 20231.92m2.67%
Hwabao WP Fund Management Co., Ltd.as of 30 Sep 20231.02m1.42%
China Fund Management Co., Ltd.as of 30 Jun 2023610.00k0.85%
China Asset Management Co., Ltd.as of 30 Jun 2023383.24k0.53%
China Southern Asset Management Co., Ltd.as of 30 Jun 2023360.74k0.50%
Chang Xin Asset Management Co., Ltd.as of 30 Jun 2023302.74k0.42%
The Vanguard Group, Inc.as of 05 Apr 2024213.09k0.30%
HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2023206.36k0.29%
GF Fund Management Co., Ltd.as of 30 Jun 2023204.14k0.28%
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.